Objective: Adding ipsilateral, proximal endovascular (IPE) intervention to carotid endarterectomy (CEA) for the treatment of tandem bifurcation and supra-aortic trunk disease is controversial. Some suggest that this combined strategy (CEA þ IPE) confers no risk over isolated CEA (ICEA). Others disagree, reserving CEA þ IPE for symptomatic patients. Using the Vascular Quality Initiative (VQI), this study assessed the effect of adding IPE to CEA on stroke and death risk. We further weighed CEA þ IPE outcomes in the context of symptomatic status and Society for Vascular Surgery guidelines.
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Questions Society for Vascular Surgery Phone: 800-258-7188; education@vascularsociety.org Results: After exclusion and identification of CEA þ IPE, 66,519 procedures were available for analysis. Of these, 66,115 represented ICEA and 404 represented CEA þ IPE. Most patients (60%) were male, 93% were white, and 41% were symptomatic. Average age was 70 6 9 years. Those undergoing CEA þ IPE were more likely to be female (50% vs 40%; P < .001) and smokers (87% vs 76%; P < .001), and they were more likely to have coronary artery disease (32% vs 27%; P ¼ .04), congestive heart failure (14% vs 10%; P ¼ .01), and chronic obstructive pulmonary disease (30% vs 22%; P < .001). ICEA patients were more likely to have severe ipsilateral stenosis (86% vs 80%; P ¼ .002) and to undergo intraoperative shunting (53% vs 49%; P ¼ .05). There was no difference in 30-day mortality between cohorts (1% vs 1%; P ¼ .23). However, CEA þ IPE had higher rates of perioperative stroke (3.0% vs 1.4%; P ¼ .01) and combined 30-day stroke and death (3.5% vs 1.8%; P ¼ .02). When patients were stratified by symptomatic status, there were no differences in primary end points between cohorts in asymptomatic patients. In symptomatic patients, CEA þ IPE carried significantly higher stroke (4.9% vs 1.9%; P ¼ .002) and stroke and death risk (6.0% vs 2.4%; P ¼ .002). After risk adjustment, predictors of stroke and death were diabetes (odds ratio [OR], 1.2; P ¼ .001), symptomatic status (OR, 1.7; P < .001), and CEA þ IPE (OR, 1.9; P ¼ .02).
Conclusions:
The addition of IPE to CEA confers increased stroke and death risk over ICEA. Risk is largely in symptomatic patients. Although CEA þ IPE increases risk compared with ICEA, overall risk remains low. Based on this VQI analysis, CEA þ IPE outcomes for asymptomatic patients fall within Society for Vascular Surgery guidelines for ICEA. Those for symptomatic patients do not, and consideration should be given to other surgical bypass, cerebral protection, and staged strategies. Management of tandem carotid bifurcation and proximal great vessel lesions is challenging. This pattern of extracranial disease often reflects a more diffuse and aggressive vascular process and affects up to 4.8% of patients with significant carotid disease. [1] [2] [3] As no diagnostic technique currently exists to determine the embolic potential or culprit characteristics of each lesion, the correction of both is often recommended. 4, 5 In the past, supra-aortic trunk lesions were exclusively treated with anatomic or extra-anatomic bypass or endarterectomy. These in combination with carotid endarterectomy (CEA) can be challenging and accompanied by the morbidity of sternotomy, thoracotomy, or complex cervical exposures. 6, 7 However, with the advent of the endovascular era, new treatment alternatives for tandem lesions have been reported. 8 The hybrid technique, in which carotid surgical exposure is followed by retrograde stenting and CEA, was first described in 1996 by Diethrich et al. 9 This approach presents an attractive alternative with easier great vessel access, hostile arch avoidance, and surgical clamp neuroprotection. Alternative hybrid techniques, such as CEA with antegrade endovascular approach, have also been described. 10 Whereas technical success of this infrequently needed hybrid procedure has been reported at 97%, 8 controversy remains about its safety and efficacy. Some purport that CEA with ipsilateral, proximal endovascular (IPE) intervention (CEA þ IPE) confers no additional risk over isolated CEA (ICEA). 4, 5, 11 Our group, identifying more complexity to these procedures along with higher rates of 30-day stroke and death, has suggested that the CEA þ IPE strategy should be reserved for symptomatic patients considered higher risk for other strategies. 12, 13 Nearly all studies examining this hybrid approach have been limited to single institutions and small patient data sets. 3, 4, 14 To this end, this study sought to assess the effect of adding IPE to CEA on stroke and death risk using the Vascular Quality Initiative (VQI). We further weighed CEA þ IPE outcomes in the context of symptomatic status and the Society for Vascular Surgery (SVS) guidelines for the treatment of extracranial carotid disease.
METHODS
The VQI of the SVS has been well described and reviewed. 15 Patients and data collection. All CEAs in the VQI were identified from participating centers in the United States from March 2003 to March 2017 and were reviewed. Urgent CEAs were excluded, as were patients with mild (#50%) ipsilateral stenosis. To ensure that each carotid artery was represented only once, any redo ipsilateral procedures listed in the VQI were also removed; redo CEAs for which the first procedure was not captured in the VQI were kept. Patients undergoing CEA plus IPE intervention were identified and composed the CEA þ IPE cohort. Patients who did not undergo concurrent IPE were reviewed, and those who underwent other concurrent procedures were excluded to provide an ICEA cohort; other concurrent procedures included distal endovascular intervention, coronary artery bypass graft, and procedures performed on arteries adjacent to the surgical site.
Demographics, medical comorbidities, and operative details were analyzed. Sixty-eight variables were collected prospectively for each procedure and recorded in the VQI database. The definitions of medical comorbidities and procedure details within the VQI, as modeled after the Vascular Study Group of New England, have been previously described. 16 Symptomatic status was defined as a history of prior neurologic event, including contralateral, ipsilateral, and vertebrobasilar events. For symptomatic stratification, patients with missing values for prior neurologic event were excluded from this subanalysis. Stroke was defined as any new neurologic deficit, regardless of symptomatic duration. Primary end points were perioperative (30-day) stroke, death, and combined stroke and death. All strokes, regardless of laterality, were included.
Statistical analysis. Statistical analysis was performed with Stata/SE 14 software (StataCorp LP, College Station, Tex). Dichotomous variables are described as a percentage of the cohort. Continuous variables are expressed as mean 6 standard deviation. Univariate analysis was performed to compare baseline clinical, operative, and demographic features and postoperative complications between the two cohorts using the c 2 test. Significant factors in univariate analysis were included in a logistic regression model to determine independent predictors of 30-day complications. A P value of #.05 was considered significant.
RESULTS
Demographics. There were 66,519 CEAs performed during the study period that met inclusion criteria. Of these, 404 represented CEA þ IPE and 66,115 were in the ICEA cohort. In this analysis, 300 VQI centers were represented, and of these, 131 (44%) performed CEA þ IPE. Of the 404 CEA þ IPE procedures, 193 (48%) were performed between 2015 and 2017. Demographic and clinical features of all included patients, stratified by cohort, are shown in Table I . Overall, 60% of the study population were male, 93% were white, 89% had hypertension, 76% were either former or current smokers, 27% had coronary artery disease (CAD), and 22% had chronic obstructive pulmonary disease (COPD). Average age was 70.4 6 9.3 years (range, 37-90 years). Most patients were taking a statin medication (81%) and antiplatelet agent (89%); 24% were receiving dual antiplatelet therapy. CEA þ IPE patients were more likely to be female (50% vs 40%; P < .001) and smokers (87% vs 76%; P < .001). Compared with CEA þ IPE, ICEA patients were less likely to have CAD (27% vs 32%; P ¼ .04), congestive heart failure (10% vs 14%; P ¼ .01), and COPD (22% vs 30%; P < .001). ICEA patients were more likely to have severe ipsilateral carotid stenosis (92% vs 87%; P < .001). Bilateral $70% stenosis was more common in CEA þ IPE patients (22% vs 17%; P ¼ .01), as was bilateral $50% stenosis (43% vs 35%; P ¼ .002). With respect to symptomatic status, the cohorts were similar (ICEA, 41%; CEA þ IPE, 45%; P ¼ .07).
Operative characteristics. The majority (89%) of patients had a patch used during repair, but CEA þ IPE patients had higher rates of patch use (92% vs 89%; P ¼ .05). The ICEA cohort was more likely to undergo intraoperative shunting (53% vs 49%; P ¼ .05) and less likely to have protamine used at the conclusion of the procedure (65% vs 73%; P ¼ .002). Completion angiography was performed in 28% of CEA þ IPE patients but in only 4% of ICEA patients (P < .001). Of the CEA þ IPE patients, 59 (15%) were identified as also having a distal endovascular intervention; however, no deaths and 3 (5%) strokes occurred in this group. The addition of this procedure did not affect outcomes. Procedure times were significantly longer in the CEA þ IPE cohort, with a mean of 155 6 71 minutes vs 114 6 43 minutes for ICEA (P < .001).
Perioperative outcomes. Overall 30-day stroke was 1.4%, with higher rates of stroke seen in the CEA þ IPE cohort (3.0% vs 1.4%; P ¼ .01). Thirty-day mortality was 0.5%, with no difference between cohorts (ICEA, 0.5%; CEA þ IPE, 1.0%; P ¼ .23). Combined stroke and death was 1.9%, with higher rates of the composite end point seen in CEA þ IPE (3.5% vs 1.8%; P ¼ .02; Table II) . When centers were stratified by volume, 7 sites performed 10 or more CEA þ IPE procedures during the study period, whereas 24 sites performed 5 or more. When each of these groups was compared with centers with lower CEA þ IPE volume (<10 or <5), no difference was seen in outcomes. In the overall cohort, more CEA þ IPE patients were receiving dual antiplatelet therapy (29% vs 24%; P ¼ .01); however, among symptomatic patients, there was no difference in dual antiplatelet status between procedures (ICEA, 29%; CEA þ IPE, 31%; P ¼ .56). In addition, no differences in primary end points were found on the basis of antiplatelet therapy either overall or stratified by symptomatic status.
ARTICLE HIGHLIGHTS
Asymptomatic patients. Fifty-nine percent (n ¼ 39,402) of patients were asymptomatic: 39,181 ICEA and 221 CEA þ IPE. In this subset of patients, CEA þ IPE were more likely to be female (50% vs 41%; P ¼ .01), to have a smoking history (85% vs 76%; P ¼ .002), and to have COPD (28% vs 22%; P ¼ .03; Table III) . When stratified by procedure, no differences were seen in any of the primary end points. Overall perioperative stroke was 1.1% (ICEA, 1.1%; CEA þ IPE, 1.4%; P ¼ .52) and death was 0.4% (ICEA, 0.4%; CEA þ IPE, 0%; P ¼ .33). The combined 30-day stroke and death end point was 1.4% (ICEA, 1.4%; CEA þ IPE; 1.4%, P ¼ .91; Table II ). Table II . Perioperative outcomes between isolated carotid endarterectomy (ICEA) and carotid endarterectomy (CEA) with ipsilateral proximal endovascular (IPE) intervention (CEA þ IPE), both in the overall cohort and stratified by symptomatic status Symptomatic patients. Forty-one percent (n ¼ 27,049) of patients were symptomatic: 26,867 ICEA and 182 CEA þ IPE. From 2013 to 2016, the number of symptomatic patients undergoing CEA þ IPE has proportionally increased from 38% to 49%, whereas that in ICEA has remained relatively static (39%-42%). In this subset of symptomatic patients, CEA þ IPE patients were more likely to be female (51% vs 39%; P ¼ .001) and to have a smoking history (90% vs 76%; P < .001), congestive heart failure (15% vs 10%; P ¼ .02), and COPD (32% vs 23%; P ¼ .002). ICEA had a higher degree of ipsilateral severe stenosis (79% vs 70%; P ¼ .02; Table IV) . When stratified by procedure, there was a significant difference seen across all primary end points. Overall perioperative stroke was 1.9% (ICEA, 1.9%; CEA þ IPE, 4.9%; P ¼ .002) and death was 0.7% (ICEA, 0.7%; CEA þ IPE, 2.2%; P ¼ .04). The combined 30-day stroke and death end point was 2.5% (ICEA, 2.4%; CEA þ IPE, 6.0%; P ¼ .002; Table II) .
Predictors of combined stroke and death. After risk adjustment with logistic regression, predictors of combined stroke and death within the entire cohort were identified. Significant predictors included CEA þ IPE (odds ratio [OR], 1.9; 95% confidence interval [CI], 1.1-3.4; P ¼ .02), diabetes (OR, 1.2; 95% CI, 1.1-1.4; P ¼ .001), CAD (OR, 1.2; 95% CI, 1.1-1.4; P ¼ .01), and symptomatic carotid disease (OR, 1.7; 95% CI, 1.5-1.9; P < .001; Table V) .
DISCUSSION
The best approach for the treatment of tandem carotid bifurcation and supra-aortic trunk disease remains controversial. As depicted in this assessment, patients with tandem lesions carry complex risk as they have greater cardiopulmonary morbidity and a more diffuse anatomic pattern of disease, and they often require multiple carotid interventions. The hybrid technique of CEA with combined proximal endovascular intervention from open cervical access was first described >20 years ago, and its technical feasibility has since been well established. 8, 9 It is an attractive option because of ease of access, relative arch avoidance, and surgical clamp neuroprotection, yet the safety and efficacy of this approach have recently been called into question. In a case series of 23 patients from our institution, we found CEA þ IPE to carry a perioperative combined stroke and death risk of 9%. 12 As we extended this study to include 62 patients across three centers, this risk was (17) 6474 (17) 48 (22) .05
Prior carotid intervention 6605 (17) 6552 (17) 53 (24) .004
Prior ipsilateral carotid intervention 687 (1. even higher at 11.3%. 13 However, both recent and older studies have reported strikingly lower rates of stroke and death. Several small cohort studies have demonstrated no 30-day strokes or deaths after the hybrid approach. 2, 11 In a meta-analysis of 133 patients across 13 studies, a 1.5% perioperative stroke and death rate was found, prompting the authors to argue that results of the hybrid approach were equal to or better than those for isolated endarterectomy. 5 Radak et al 10 recently reported a retrospective review of 18 patients undergoing antegrade, transfemoral proximal stenting under open clamp neuroprotection followed by eversion CEA with no perioperative stroke or death.
In this study, we used the VQI to further elucidate operative outcomes of CEA with proximal endovascular intervention and found CEA þ IPE to carry a higher 30-day combined stroke and death rate compared with ICEA (3.5% vs 1.8%; P ¼ .02). On logistic regression, it is clear that CEA þ IPE does indeed carry an independent risk of stroke and death over ICEA (OR, 1.9; P ¼ .02). Whereas this risk remains significantly increased over ICEA, the overall risk is seemingly low. This generally low risk of CEA þ IPE in the VQI is somewhat in contradistinction to our previous reports. It is likely related to the data reporting nature of the VQI, general infrequency of the procedure within institutions, broad lesion characteristics, selection biases for the procedure across VQI centers, and our center's historical preference for open surgical reconstruction with higher risk selection bias for use of CEA þ IPE.
Symptomatic status is an important consideration in the management of tandem disease and in the selection of patients suitable for hybrid, multilevel carotid revascularization. Yet the literature is varied on this topic, and to our knowledge, no study has focused exclusively on this issue. In the two most recent studies by Clouse et al, 12 ,13 the proportion of symptomatic patients was low (35%-42%), and yet perioperative stroke/death rates were high, ranging from 9% to 11%. In contrast, Levien et al 4 found in their retrospective analysis of 44 symptomatic patients undergoing CEA þ IPE by a single surgeon that no perioperative stroke or death occurred. Other small (<13 patients) studies, with varying percentages of symptomatic patients (25%-83%), have also reported no perioperative stroke/death after the hybrid approach. 2, 11, 14 The metaanalysis by Sfyroeras et al 5 of 133 patients, 83% of whom were symptomatic, cited an overall perioperative stroke/death rate of 1.5%. In our study, 41% of patients were symptomatic, and we found a 30-day stroke and death rate of 3.5% with CEA þ IPE.
To further elucidate this issue, we chose to stratify patients by symptomatic status and to reassess perioperative outcomes. The results were analyzed within the context of Societal guidelines for ICEA, which denote acceptable CEA perioperative stroke/death rates of #3% in asymptomatic patients and <6% in symptomatic patients. 17, 18 Among asymptomatic patients, perioperative stroke/death was 1.4%, and there was no difference in the combined end point between the two operative cohorts (ICEA, 1.4%; CEA þ IPE, 1.4%; P ¼ .91). However, differences in outcomes were significant in symptomatic patients. In this group, overall 30-day stroke/death was 2.5% and higher in CEA þ IPE patients (ICEA, 2.4%; CEA þ IPE, 6.0%; P ¼ .002). Furthermore, in addition to CEA þ IPE, symptomatic status was the next major significant predictor of stroke/death (OR, 1.7; P < .001) on logistic regression. These data suggest that in patients without prior neurologic event, CEA þ IPE does not confer additional risk over ICEA and outcomes meet SVS CEA criteria; thus, CEA þ IPE may be a reasonable option in asymptomatic patients. However, in symptomatic patients, the 6% stroke/death outcome falls outside of recommended guidelines for ICEA. Interestingly, this analysis found that the percentage of symptomatic patients undergoing CEA þ IPE has steadily increased during the past 5 years. This observation likely stems from increasing familiarity of providers and preference for endovascular reconstructive therapies as well as limited data on CEA þ IPE outcomes in symptomatic patients. Duplex ultrasound imaging and physical examination remain important components in the assessment of proximal lesion hemodynamic implications 12 ; the tenet of normalization of inflow seems fundamental. Some would question the need for proximal intervention in asymptomatic patients. However, the fact remains that within the current limitations of today's imaging technology, it can be difficult to ascertain true embolic potential of supra-aortic trunk lesions. The natural history and associated risk of untreated proximal great vessel disease deserve further study. In symptomatic patients, most would at least consider the treatment of both lesions, as the true culprit is usually impossible to pinpoint with certainty. Isolated endovascular intervention, full open surgical reconstruction, and staged hybrid procedures provide possible alternative approaches.
Historically, direct open reconstruction of the great vessels has been reported with substantial rates of morbidity and mortality, with perioperative stroke/death rates ranging from 4% to 16%. 6, 19 However, as extrathoracic reconstruction has generally superseded the transthoracic approach, improvements in perioperative outcomes have been achieved. 20 In an assessment of 148 patients treated with tandem disease using CEA in conjunction with subclavian-carotid bypass or transposition, Risty et al 7 Expanding study into three institutions comprising 62 patients, with all proximal lesions stented, we found restenosis in 34% occurring with similar frequency at both the CEA and IPE sites. Estimated freedom from restenosis was only 66% at 5 years. 13 The meta-analysis of 13 studies and 133 patients found that only 3.7% of patients with a proximal stent implanted developed restenosis compared with 14% of patients who had simple balloon angioplasty. 5 Most small case series do not provide exact stent detail in the treatment of the supra-aortic trunk lesions, nor do they report any fashion of follow-up information. [2] [3] [4] 11, 14 Our report in 62 CEA þ IPE patients estimated freedom from stroke at 86% and 84% at 1 year and 5 years, respectively. Freedom from reintervention was 93% at 1 year and 81% at 5 years. Seemingly, the stroke risk is borne procedurally, yet these scant data suggest that CEA þ IPE durability is likely to be inferior to full surgical reconstruction, with selection of the patient and lesion crucial. There are several limitations to the study. One limitation lies in its retrospective review of a prospectively maintained database, prone to entry errors and missing data; the VQI performs regular audits to minimize these issues. In addition, the lack of procedural detail prevents us from commenting on proximal lesion anatomy and characteristics, CEA and IPE temporal conduct, and use and extent of stenting vs angioplasty alone. The nature of neuroprotection is also unknown. Currently, the VQI does not collect detailed information on concurrent arterial reconstructions and simply notes whether a procedure on an adjacent artery was performed at the time of CEA. This limits our current VQI analysis as it does not allow direct comparison of CEA þ IPE with open surgical proximal reconstructive strategies combined with CEA. Nearly half of CEA þ IPE procedures identified were performed after 2015, and a time frame bias may exist. As noted, we are unable to assess and to comment on long-term outcomes. As the VQI includes only a subset of hospital centers and does not include the Veterans Affairs population, these data may not be fully representative of national practice patterns and outcomes.
CONCLUSIONS
The addition of IPE intervention to CEA confers increased combined stroke and death risk over ICEA. However, overall risk remains low. When stratified by symptomatic status, the added risk is largely in symptomatic patients. Within the context of Societal ICEA guideline criteria, CEA þ IPE meets SVS guidelines for ICEA in asymptomatic patients. However, the combined perioperative stroke and death rate of 6% in symptomatic CEA þ IPE patients falls outside of recommendations. This VQI analysis suggests that consideration for other reconstructive strategies should be given for symptomatic patients with tandem bifurcation and supra-aortic trunk disease within the context of their overall operative risk profile.
